
Lakia J. Jackson-tongue
Examiner (ID: 2679, Phone: (571)272-2921 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 887 |
| Issued Applications | 525 |
| Pending Applications | 105 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10373195
[patent_doc_number] => 20150258201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'Combined enteropathogen recombinant construct'
[patent_app_type] => utility
[patent_app_number] => 14/721656
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13377
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721656
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/721656 | Combined enteropathogen recombinant construct | May 25, 2015 | Issued |
Array
(
[id] => 10373195
[patent_doc_number] => 20150258201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'Combined enteropathogen recombinant construct'
[patent_app_type] => utility
[patent_app_number] => 14/721656
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13377
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721656
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/721656 | Combined enteropathogen recombinant construct | May 25, 2015 | Issued |
Array
(
[id] => 12384543
[patent_doc_number] => 09962414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Probiotic recolonisation therapy
[patent_app_type] => utility
[patent_app_number] => 14/710487
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5799
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14710487
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/710487 | Probiotic recolonisation therapy | May 11, 2015 | Issued |
Array
(
[id] => 10353539
[patent_doc_number] => 20150238545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'PROBIOTIC RECOLONISATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/710481
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5981
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14710481
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/710481 | PROBIOTIC RECOLONISATION THERAPY | May 11, 2015 | Abandoned |
Array
(
[id] => 11499244
[patent_doc_number] => 20170073430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'NOVEL ANTI-RNF43 ANTIBODIES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/305861
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 48680
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305861 | NOVEL ANTI-RNF43 ANTIBODIES AND METHODS OF USE | Apr 20, 2015 | Abandoned |
Array
(
[id] => 10331949
[patent_doc_number] => 20150216953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/689390
[patent_app_country] => US
[patent_app_date] => 2015-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14629
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14689390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/689390 | Botulinum toxin therapy for skin disorders | Apr 16, 2015 | Issued |
Array
(
[id] => 14324023
[patent_doc_number] => 10293004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Butyrate-producing bacterium and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/129849
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8428
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15129849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/129849 | Butyrate-producing bacterium and use thereof | Mar 26, 2015 | Issued |
Array
(
[id] => 10312556
[patent_doc_number] => 20150197558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'BINDING MOIETIES FOR BIOFILM REMEDIATION'
[patent_app_type] => utility
[patent_app_number] => 14/668767
[patent_app_country] => US
[patent_app_date] => 2015-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9336
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14668767
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/668767 | BINDING MOIETIES FOR BIOFILM REMEDIATION | Mar 24, 2015 | Abandoned |
Array
(
[id] => 10306749
[patent_doc_number] => 20150191749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'Essential Genes Encoding Conserved Metabolic Pathway Function in Autotrophic Solventogenic Clostridial Species'
[patent_app_type] => utility
[patent_app_number] => 14/665894
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5301
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665894
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/665894 | Essential Genes Encoding Conserved Metabolic Pathway Function in Autotrophic Solventogenic Clostridial Species | Mar 22, 2015 | Abandoned |
Array
(
[id] => 14147851
[patent_doc_number] => 10254296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Qualitative predictive method for differential diagnosis of pneumococcal meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis
[patent_app_type] => utility
[patent_app_number] => 15/121869
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10064
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121869
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/121869 | Qualitative predictive method for differential diagnosis of pneumococcal meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis | Feb 23, 2015 | Issued |
Array
(
[id] => 13153985
[patent_doc_number] => 10093704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Expression and purification of CRM197 and related proteins
[patent_app_type] => utility
[patent_app_number] => 15/114642
[patent_app_country] => US
[patent_app_date] => 2015-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7047
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114642
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/114642 | Expression and purification of CRM197 and related proteins | Feb 1, 2015 | Issued |
Array
(
[id] => 11641030
[patent_doc_number] => 09662380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'C. perfringens alpha toxoid vaccine'
[patent_app_type] => utility
[patent_app_number] => 14/608577
[patent_app_country] => US
[patent_app_date] => 2015-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16264
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14608577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/608577 | C. perfringens alpha toxoid vaccine | Jan 28, 2015 | Issued |
Array
(
[id] => 14258881
[patent_doc_number] => 10278984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Guanosine as an immune potentiator mediated through toll receptors
[patent_app_type] => utility
[patent_app_number] => 15/306876
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 4994
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306876
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/306876 | Guanosine as an immune potentiator mediated through toll receptors | Dec 18, 2014 | Issued |
Array
(
[id] => 10281616
[patent_doc_number] => 20150166613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A'
[patent_app_type] => utility
[patent_app_number] => 14/571546
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 27373
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571546
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/571546 | Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A | Dec 15, 2014 | Issued |
Array
(
[id] => 11177971
[patent_doc_number] => 09409957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A'
[patent_app_type] => utility
[patent_app_number] => 14/571807
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 28
[patent_no_of_words] => 27068
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14571807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/571807 | Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin A | Dec 15, 2014 | Issued |
Array
(
[id] => 9895119
[patent_doc_number] => 20150050318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'MULTIVALENT NANOEMULSION VACCINES'
[patent_app_type] => utility
[patent_app_number] => 14/532745
[patent_app_country] => US
[patent_app_date] => 2014-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 46607
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14532745
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/532745 | MULTIVALENT NANOEMULSION VACCINES | Nov 3, 2014 | Abandoned |
Array
(
[id] => 9864234
[patent_doc_number] => 20150044254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/522254
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18701
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14522254
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/522254 | Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells | Oct 22, 2014 | Issued |
Array
(
[id] => 15915347
[patent_doc_number] => 10654902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria
[patent_app_type] => utility
[patent_app_number] => 14/513797
[patent_app_country] => US
[patent_app_date] => 2014-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 35
[patent_no_of_words] => 29660
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14513797
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/513797 | Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria | Oct 13, 2014 | Issued |
Array
(
[id] => 9838532
[patent_doc_number] => 20150030612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'IMMUNIZATION AGAINST CLOSTRIDIUM DIFFICILE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/512216
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9022
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512216
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/512216 | IMMUNIZATION AGAINST CLOSTRIDIUM DIFFICILE DISEASE | Oct 9, 2014 | Abandoned |
Array
(
[id] => 10201573
[patent_doc_number] => 20150086561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'BINDING MOIETIES FOR BIOFILM REMEDIATION'
[patent_app_type] => utility
[patent_app_number] => 14/497147
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7076
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14497147
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/497147 | BINDING MOIETIES FOR BIOFILM REMEDIATION | Sep 24, 2014 | Abandoned |